Mutual of America Capital Management LLC Reduces Stock Holdings in Encompass Health Co. (NYSE:EHC)

Mutual of America Capital Management LLC cut its position in shares of Encompass Health Co. (NYSE:EHC) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 62,685 shares of the company’s stock after selling 2,025 shares during the period. Mutual of America Capital Management LLC owned 0.06% of Encompass Health worth $5,789,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in EHC. Wealth Enhancement Advisory Services LLC boosted its holdings in Encompass Health by 1.5% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 13,151 shares of the company’s stock worth $1,271,000 after buying an additional 199 shares in the last quarter. State of Alaska Department of Revenue boosted its holdings in Encompass Health by 6.5% during the third quarter. State of Alaska Department of Revenue now owns 12,866 shares of the company’s stock worth $1,242,000 after buying an additional 790 shares in the last quarter. First Trust Direct Indexing L.P. boosted its holdings in Encompass Health by 11.9% during the third quarter. First Trust Direct Indexing L.P. now owns 2,851 shares of the company’s stock worth $276,000 after buying an additional 304 shares in the last quarter. US Bancorp DE boosted its holdings in Encompass Health by 18.7% during the third quarter. US Bancorp DE now owns 1,259 shares of the company’s stock worth $122,000 after buying an additional 198 shares in the last quarter. Finally, Janney Montgomery Scott LLC boosted its holdings in Encompass Health by 5.5% during the third quarter. Janney Montgomery Scott LLC now owns 11,357 shares of the company’s stock worth $1,098,000 after buying an additional 597 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

EHC has been the topic of several recent analyst reports. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Finally, KeyCorp increased their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. Ten research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $107.67.

Encompass Health Price Performance

Shares of NYSE EHC opened at $99.73 on Tuesday. The firm has a 50-day simple moving average of $96.53 and a 200-day simple moving average of $96.50. The stock has a market capitalization of $10.05 billion, a price-to-earnings ratio of 22.36, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52 week low of $74.27 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, equities analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s payout ratio is currently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.